| Primary |
| Growth Hormone Deficiency |
19.4% |
| Hypopituitarism |
15.8% |
| Drug Use For Unknown Indication |
13.0% |
| Product Used For Unknown Indication |
5.8% |
| Hypertension |
4.3% |
| Hypothyroidism |
4.3% |
| Blood Corticotrophin Decreased |
4.1% |
| Blood Thyroid Stimulating Hormone Decreased |
3.9% |
| Blood Follicle Stimulating Hormone Decreased |
3.7% |
| Blood Luteinising Hormone Decreased |
3.6% |
| Hypogonadism |
3.2% |
| Primary Hypothyroidism |
3.0% |
| Adrenal Insufficiency |
2.5% |
| Secondary Hypothyroidism |
2.3% |
| Hyperlipidaemia |
2.1% |
| Diabetes Insipidus |
1.8% |
| Small For Dates Baby |
1.8% |
| Depression |
1.8% |
| Turner's Syndrome |
1.8% |
| Diabetes Mellitus |
1.7% |
|
| Death |
18.8% |
| Pituitary Tumour Benign |
12.7% |
| Craniopharyngioma |
7.7% |
| Neoplasm Recurrence |
7.5% |
| Meningioma |
5.9% |
| Prostate Cancer |
4.6% |
| Tonsillar Hypertrophy |
4.4% |
| Sleep Apnoea Syndrome |
4.2% |
| Osteonecrosis |
4.0% |
| Pneumonia |
3.8% |
| Vomiting |
3.2% |
| Astrocytoma |
3.0% |
| Pituitary Tumour Recurrent |
2.8% |
| Brain Neoplasm |
2.6% |
| Malignant Melanoma |
2.6% |
| Osteochondrosis |
2.6% |
| Germ Cell Cancer |
2.4% |
| Scoliosis |
2.4% |
| Adenoidal Hypertrophy |
2.2% |
| Adrenocortical Insufficiency Acute |
2.2% |
|
| Secondary |
| Growth Hormone Deficiency |
15.5% |
| Hypopituitarism |
9.8% |
| Blood Corticotrophin Decreased |
9.0% |
| Blood Thyroid Stimulating Hormone Decreased |
6.9% |
| Blood Follicle Stimulating Hormone Decreased |
6.7% |
| Blood Luteinising Hormone Decreased |
6.7% |
| Drug Use For Unknown Indication |
5.9% |
| Product Used For Unknown Indication |
4.3% |
| Secondary Adrenocortical Insufficiency |
3.5% |
| Small For Dates Baby |
3.5% |
| Hiv Infection |
3.2% |
| Secondary Hypothyroidism |
3.1% |
| Epilepsy |
2.9% |
| Blood Antidiuretic Hormone Decreased |
2.9% |
| Acquired Immunodeficiency Syndrome |
2.8% |
| Convulsion |
2.8% |
| Hypogonadism |
2.8% |
| Diabetes Mellitus |
2.6% |
| Primary Hypothyroidism |
2.6% |
| Hypothyroidism |
2.3% |
|
| Neoplasm Recurrence |
12.2% |
| Craniopharyngioma |
10.6% |
| Pituitary Tumour Benign |
9.4% |
| Fracture |
5.5% |
| Osteochondrosis |
5.5% |
| Death |
5.1% |
| Accident |
4.7% |
| Ligament Sprain |
4.7% |
| No Adverse Event |
4.7% |
| Bronchitis |
3.9% |
| Germ Cell Cancer |
3.9% |
| Post Procedural Infection |
3.9% |
| Prostate Cancer |
3.5% |
| Brain Neoplasm |
3.1% |
| Eye Disorder |
3.1% |
| Febrile Convulsion |
3.1% |
| Loss Of Consciousness |
3.1% |
| Metabolic Acidosis |
3.1% |
| Neoplasm |
3.1% |
| Sleep Apnoea Syndrome |
3.1% |
|
| Concomitant |
| Hiv Infection |
27.8% |
| Drug Use For Unknown Indication |
18.3% |
| Product Used For Unknown Indication |
17.6% |
| Hypopituitarism |
6.0% |
| Crohn's Disease |
2.8% |
| Hepatitis C |
2.8% |
| Juvenile Arthritis |
2.5% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Cystinosis |
2.1% |
| Factor Viii Deficiency |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Hypertension |
1.8% |
| In Vitro Fertilisation |
1.8% |
| Pain |
1.8% |
| Asthma |
1.4% |
| Body Height Below Normal |
1.4% |
| Dialysis |
1.4% |
| Growth Hormone Deficiency |
1.4% |
| Haemophilia |
1.4% |
| Insomnia |
1.4% |
|
| Osteonecrosis |
9.6% |
| Hypertension |
7.7% |
| Sepsis |
7.7% |
| Skin Striae |
7.7% |
| Walking Disability |
7.7% |
| Staphylococcal Infection |
5.8% |
| Astrocytoma |
3.8% |
| Atrial Fibrillation |
3.8% |
| Drug Administered At Inappropriate Site |
3.8% |
| Loss Of Consciousness |
3.8% |
| Nausea |
3.8% |
| Oliguria |
3.8% |
| Overdose |
3.8% |
| Rash Vesicular |
3.8% |
| Renal Failure Acute |
3.8% |
| Therapeutic Response Decreased |
3.8% |
| Thrombocytopenia |
3.8% |
| Uveitis |
3.8% |
| Viral Infection |
3.8% |
| Vomiting |
3.8% |
|
| Interacting |
|
|
